Products in brief | Sun Pharma, Bountiful, AFT

Products in brief | Sun Pharma, Bountiful, AFT
Sun Pharma Consumer Healthcare has launched Revital NXT in India

13 September 2021 - Deborah Wilkes

Sun Pharma has entered the nutrition bar segment in India with its Revital brand, The Bountiful Company has extended Sundown Kids in the US, and AFT Pharmaceuticals is seeking a change to the classification of ibuprofen in New Zealand.

Sun Pharma enters nutrition bar segment

Sun Pharma Consumer Healthcare has entered the nutrition bar segment in India with a line extension to its Revital H vitamins, minerals and supplements (VMS) brand.

The Revital NXT nutrition bar is available in two variants – Revital Energy NXT and Revital Protein NXT. Like Revital H, they contain ginseng.

Sun Pharma said Revital NXT was India’s first nutrition bar with the “goodness of natural ginseng, 16 vitamins and minerals, and triple blend protein”.

The bars have been launched on Amazon and will also be made available on other e-commerce platforms.

Commenting on the launch, Vidhi Shanghvi, head of Sun Pharma Consumer Healthcare, said Revital H had been the “bellwether of the nutritional supplement segment, helping consumers live stronger, healthier lives for over three decades”.

Shanghvi added that increasing health consciousness and active lifestyles meant there was “rising demand for on-the-go nutrition”.

Bountiful extends Sundown Kids

The Bountiful Company has extended its Sundown Kids vitamins, minerals and supplements (VMS) brand in the US with two immune health products.

The company said Sundown Kids Vitamin C Gummies and Sundown Kids Vitamin D3 Gummies were now available from CVS stores and Amazon.

“This new line designed to support a child’s immune system is non-GMO, gluten- and dairy-free, and never made with artificial flavours,” said Bountiful, adding “parents can feel confident these are clean vitamins they can count on”.

The Bountiful Company is part of Nestlé Health Science (click here to read the News story).

AFT seeks ibuprofen change in New Zealand

AFT Pharmaceuticals is seeking a change to the classification of ibuprofen in New Zealand which would allow it to sell Maxigesic Cold & Flu Hot Drink Double Strength without a prescription.

The company wants ibuprofen 300mg in powder form to be reclassified from a prescription medicine to a pharmacist only medicine for oral use.

The maximum recommended daily dose would be 1200mg and the maximum pack size would be 12 sachets. The product would be suitable for adults and children over 12 years of age.

Larger packs containing 13-50 sachets would remain prescription medicines.

AFT’s application will be considered by New Zealand’s Medicines Classification Committee (MCC) at its next meeting on 26 October 2021.

Maxigesic Cold & Flu Hot Drink Double Strength is a fixed combination containing 300mg ibuprofen and 1000mg paracetamol per sachet.

Click tags below for more information on topics:

Nestlé AFT

Back to Industry News

Share this page: